Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico.

Sergio Sauri-SuarezSandra QuiñonesManuel De la Maza-FloresArturo Marin-ContrerasGil Playas-PérezBrenda Bertado-CortésFrancisco Frias-MarquezGilberto Zuñiga-GarcíaFrancisco Rodriguez-LealCarlos Blaisdell-VidalEnrique Gomez-Figueroa

Published in: Multiple sclerosis journal - experimental, translational and clinical (2024)

Cladribine showed early and effective control of active MS in Mexican patients, demonstrating a secure profile with minimal adverse events. This study provides valuable real-world evidence in the LATAM context.

Keyphrases

multiple sclerosis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
mass spectrometry
peritoneal dialysis
prognostic factors